MAIN 10-Q report for 2026-03-31
Main Street Capital Corporation filed its Form 10-Q for the quarter ended March 31, 2026. The filing includes consolidated financial statements, a detailed schedule of investments, MD&A table of contents, and quarter-to-quarter comparisons of investment income, expenses, realized/unrealized gains (losses), cash flow and capital activity.
Linked assets
MAIN (Main Street Capital Corporation) — quarterly filing contains consolidated balance sheet, statements of operations, cash flows, schedules of investments and notes for the quarter ended March 31, 2026. No other tickers are the primary subject of this filing.
Main Street Capital Corporation (MAIN) Form 10-Q for the quarter ended March 31, 2026. Key reported figures: total assets $5,828,398k; total investments at fair value $5,674,751k; total liabilities $2,734,754k; total net assets $3,093,644k; NAV per share $33.46 (Mar 31, 2026) vs $33.33 (Dec 31, 2025). Three-month results: total investment income $140,106k; net investment income $84,579k; net increase in net assets from operations $48,981k. Cash and cash equivalents declined to $20,791k from $41,959k. Financing and investing activity included $391,937k of investments in portfolio companies and $200,000k proceeds from March 2029 notes offering; net cash used in operating activities was $(138,544)k. Shares outstanding were 92,462,273 as of March 31, 2026.
The Form 10-Q includes consolidated financial statements and a detailed consolidated schedule of investments as of March 31, 2026. Highlights from the filing: total investments at fair value increased to $5,674,751k (cost $4,933,484k); NAV rose to $3,093,644k with NAV per share $33.46. Investment income for the quarter was $140,106k; net investment income was $84,579k. The company recorded net realized gains of $17,973k and net unrealized depreciation of $(50,599)k, producing a net increase in net assets from operations of $48,981k for the quarter. Cash and cash equivalents declined to $20,791k, driven by $391,937k of new investments and net cash used in operating activities of $(138,544)k, partially offset by financing proceeds including $134,283k from a public equity offering and $200,000k from issuance of March 2029 notes. Total liabilities included multiple note issuances and SBIC debentures; credit facilities outstanding were $386,000k. The filing contains full notes, schedules of investments by portfolio company, and MD&A table of contents but should be read in full for risk factors, liquidity discussion and other disclosures before acting on the stock. This play is classified as active with a recommended strategy of sell; the filing itself is factual reporting rather than an explicit operational catalyst.
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
Primary source: MAIN Form 10-Q for the quarter ended March 31, 2026. The filing contains audited (unaudited interim) consolidated financial statements, a full consolidated schedule of investments as of March 31, 2026, and the table of contents listing MD&A, market risk disclosure, controls and procedures, and other required SEC sections.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic 'company filed its 10‑Q' metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
The provided text is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
One author contributed to the summary bundle metadata. The play package consolidates SEC filing excerpts and internal analysis notes; it does not add new financial assertions beyond what is presented in the filing.
Unlock full thesis monitoring
Review MAIN’s 10-Q for full financial statements, schedule of investments and MD&A before making investment decisions. The recommended strategy in this play is: sell (status: active, outcome: open).